Navigation Links
Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments
Date:8/12/2011

PRINCETON, N.J., Aug. 12, 2011 /PRNewswire/ -- Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today its financial results for the second quarter of 2011.

Soligenix’s revenues for the second quarter of 2011 were approximately $406,000 as compared to $445,000 for the second quarter of 2010. The slight decrease in revenues was primarily a result of completion in April 2011 of the initial year of its FDA Orphan Products grant for the confirmatory Phase 3 clinical trial of orBec® in acute gastrointestinal Graft-versus-Host disease (GI GVHD).

Soligenix’s net loss for the second quarter of 2011 was approximately $1,931,000, or $(0.01) per share, as compared to $1,577,000, or $(0.01) per share for the second quarter of 2010. This higher net loss was related to increased R&D costs in connection with the conduct of the confirmatory Phase 3 clinical trial of orBec® in GI GVHD.

Research and development expenses for the second quarter of 2011 were approximately $1,307,000, as compared to $1,071,000 for the second quarter of 2010. General and administrative expenses for the second quarter of 2011 were approximately $450,000, compared to approximately $545,000 for the second quarter of 2010.

As of June 30, 2011, the Company’s cash position was approximately $4,157,000 with working capital of $3,166,000, which increased on July 28, 2011 when the Company expanded its partnership with Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau) in Europe and received an up-front payment of $5,000,000.  

“The summer of 2011 has been eventful for us,” stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. “The expanded partnership with Sigma-Tau into Europe brought $5 million in non-dilutive financing into the Company and also establishes a mechanism to effectively launch and market orBec® in the second major w
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
2. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
3. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
4. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
5. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
6. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
7. Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT
8. Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
9. Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT
10. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
11. Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... -- EU5 Capsule Endoscopy Systems Market Outlook to 2020 ... "EU5 Capsule Endoscopy Systems Market Outlook to 2020", provides ... market. The report provides value, in millions of US ... dollars) within market segments - Capsule Endoscopes, Capsule Endoscopy ... report also provides company shares and distribution shares data ...
(Date:9/29/2014)... 2014 EU5 Sigmoidoscopes Market Outlook to ... Sigmoidoscopes Market Outlook to 2020", provides key market ... provides value, in millions of US dollars, volume ... within market segments - Flexible Video Sigmoidoscopes and ... (Fibre) Sigmoidoscopes). The report also provides ...
(Date:9/29/2014)... -- Following US and European approvals of Elekta,s Versa ... Administration (CFDA) has cleared the radiation therapy system for ... to the International Agency for Research on Cancer, well ... year in China 1 , ... and esophageal cancers 2 . Versa HD is designed ...
Breaking Medicine Technology:EU5 Capsule Endoscopy Systems Market Outlook to 2020 2EU5 Capsule Endoscopy Systems Market Outlook to 2020 3EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 2Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 3
... 2012  Amgen (NASDAQ: AMGN ) will present at ... at the Four Seasons Hotel, Chicago, Ill., beginning at 8:20 ... Relations at Amgen, will present. Live audio of the presentation ... www.amgen.com , under Investors. About ...
... (Nasdaq: ESRX ) announced that it will present ... on May 16, 2012 at 1:00 p.m. PDT (4:00 p.m. ... Nevada. This presentation will also be broadcast via ... section of Express Scripts, web site at http://www.express-scripts.com   ...
Cached Medicine Technology:
(Date:9/30/2014)... 2014 Computer Resources of America, ... based in New York City, has been awarded ... to transform, manage, and support the IT environment ... a leading provider of innovative services that enable ... The contract will cover the four NY-metro ...
(Date:9/30/2014)... Albany, IN (PRWEB) September 30, 2014 ... Dr. Ron Receveur encourages all persons who have received ... disease in a recent blog post. , The post, ... those with dental implants that if they don’t brush ... the same way people lose their natural teeth: the ...
(Date:9/30/2014)... Ontario, Canada (PRWEB) September 30, 2014 ... diagnostic imaging services based in San Juan, Puerto ... automate their workflows. , Nivia Souffront, site ... to their facility. “We are excited to bring ... to provide better patient care and physician satisfaction ...
(Date:9/30/2014)... September 30, 2014 3M has added four ... high bond tapes. 3M 5906 , 3M 5907 ... are conformable VHBs which help create the strongest bond possible ... are used for bonding to difficult surfaces such as paints, ... 5906, 5907, 5908, and 5905 are designed specifically for electronic ...
(Date:9/30/2014)... FL (PRWEB) September 30, 2014 Doctors often ... received abnormal mammogram results. Most breast ultrasounds are done ... Center for Diagnostic Imaging in Miami . The Center ... as an alternative to MRI. Most patients find ultrasounds ... open space and do not have to remain perfectly still. ...
Breaking Medicine News(10 mins):Health News:CRA Awarded Managed Services Contract for Large NYC Nonprofit 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 3Health News:Signet Puerto Rico Leverages PowerServer RIS/PACS/PM™ to Improve Patient Care, Cut Costs 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 3Health News:Breast Ultrasounds Are a Comfortable and Convenient Option for Patients and Referring Doctors 2
... seem to be in the grips of a mumps ... officials suspect// that it spread easily to the other ... have helped spread the infection to the other states. ... diseases can spread easily through air travel. According to ...
... first heart transplant patient whose donor heart was removed ... operation was performed on the school girl, Hannah Clark, 12, ... body rejected her 10-yeat-old "piggy-back" heart, the nickname for the ... with the new one surgically attached to it. ...
... emergency services, in ten government medical college hospitals in ... mount pressure on the government in support of their ... Students Association are on an indefinite strike demanding the ... concession to the in-service doctors in admission to the ...
... that the ?6.2bn upgrade of the NHS IT system ... magazine said that the group of academics are questioning if ... saying that the plan was under a "constant review" and ... 30,000 GPs in England to almost 300 hospitals by 2012. ...
... Rajkumar (77), Kannada superstar and winner of the prestigious Dada ... hospital this afternoon. //The superstar had come in the limelight ... for more than 100 days, about six years ago, according ... of Kannada thespian Rajkumar were donated to an eye Bank, ...
... of Technology are developing a kind of lab-on-a-chip which ... //,This would benefit astronauts on long missions, who will ... to diagnose infection, allergies, anemia or deficiencies in the ... by the National Space Biomedical Research Institute (NSBRI). ...
Cached Medicine News:Health News:Donor Heart Gives Way for Patient’s Own Hear 2Health News:Technology at its nano best: hand-held lab-on-a-chip for blood tests 2
... Micro Anchor is the smallest, strongest ... flexibility in placement into even the ... with 3-0 or 4-0 ETHIBOND EXCEL ... or cutting swaged needles. The kit ...
... a threaded titanium anchor, specifically ... The anchor features wide threads ... optimize bone purchase, as well ... prevent suture binding. Fastin RC ...
The GII titanium anchor is the "Gold Standard" for soft tissue reattachment to bone. The GII's small size, high pull-out strength and wide range of clinical applications make it the anchor of choice ...
... Proxis features 'proximal protection' -- providing ... removal, even in vessels with side branches. ... to use. It does not require the ... removal of embolic debris. ,Proxis is ...
Medicine Products: